| 000 | 01885 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517182111.0 | ||
| 264 | 0 | _c20180716 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1816-5370 | ||
| 024 | 7 |
_a10.1177/0218492317737641 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Kanghoon | |
| 245 | 0 | 0 |
_aPost-recurrence survival analysis of stage I non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bAsian cardiovascular & thoracic annals _cNov 2017 |
||
| 300 |
_a623-629 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xgenetics |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKim, Hyeong Ryul | |
| 700 | 1 | _aKim, Dong Kwan | |
| 700 | 1 | _aKim, Yong-Hee | |
| 700 | 1 | _aPark, Seung-Ill | |
| 700 | 1 | _aChoi, Se Hoon | |
| 700 | 1 | _aHan, Junhee | |
| 773 | 0 |
_tAsian cardiovascular & thoracic annals _gvol. 25 _gno. 9 _gp. 623-629 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0218492317737641 _zAvailable from publisher's website |
| 999 |
_c27711282 _d27711282 |
||